Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 101.34 M99 M112.63 M115.27 M116.25 M 443.15 M Research & development ————— — Operating income 78.42 M81.14 M76.17 M78.02 M91.83 M 327.16 M Non-Operating Income, Total 1.75 M3.6 M-1.48 M-2.57 M-425 K -874 K Interest expense, net of interest capitalized 4.14 M4.28 M4.92 M4.26 M3.95 M 17.42 M Non-Operating Income, excl. Interest Expenses -2.95 M-2.07 M-5.94 M-3.79 M-2.82 M -14.62 M Unusual income/expense 4.7 M5.67 M4.46 M1.22 M2.39 M 13.74 M Pretax income 80.06 M84.6 M74.62 M75.48 M91.4 M 326.09 M Equity in earnings -109 K-141 K-80 K25 K-2 000 -198 K Taxes 13.5 M18.55 M16.46 M15.23 M24.32 M 74.55 M Non-controlling/minority interest ————— — After tax other income/expense -1.44 M-139 K-394 K-1.91 M-496 K -2.94 M Net income before discontinued operations 66.56 M66.05 M58.16 M60.25 M67.08 M 251.54 M Discontinued operations ————— — Net income 66.56 M66.05 M58.16 M60.25 M67.08 M 251.54 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 66.56 M66.05 M58.16 M60.25 M67.08 M 251.54 M Basic earnings per share (Basic EPS) 0.410.410.360.380.43 1.58 Diluted earnings per share (Diluted EPS) 0.40.40.360.380.43 1.57 Average basic shares outstanding 162.49 M162.93 M160.5 M161.03 M156.05 M — Diluted shares outstanding 164.56 M164.19 M161.71 M162.48 M156.9 M — EBITDA 77.15 M82.26 M76.85 M76.66 M86.59 M 322.37 M EBIT 63.61 M68.11 M61.67 M60.29 M72.59 M 262.66 M Cost of revenue 322.51 M333.3 M340.16 M350.71 M367.5 M 1.39 B Other cost of goods sold 307.7 M320.27 M325.65 M332.98 M348.27 M 1.33 B Depreciation & amortization (cash flow) 13.54 M14.15 M15.19 M16.37 M13.99 M 59.7 M